Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aravive, Avexis, Fulcrum, Leading Biosciences, Milestone, Novartis, Novavax, Oncolytics, Oncopeptides, Oncoquest, Partner, Rafael, Seelos.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axsome, Immutep, Theralase.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Bellus, Biondvax, Bioxcel, Cellphire, Genentech, GT Biopharma, ISA, Nantkwest, Novartis, Oramed, Pfizer, Phathom, Soligenix, TFF.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Enlivex, Graybug, Ideaya, Iveric, Sellas, Vivoryon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abeona, Adial, Arch, Astrazeneca, Blueprint, Eton, Inventiva, Inxmed, Lattice, Merck, Oncosec, Provention, Recce, Surface Oncology.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Aimmune, Aptevo, Arcutis, Biocryst, Can-Fite, Genetx, Moderna, Novo Nordisk, Regeneron, Sanofi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Artugen, EMD Serono, Five Prime, Pfizer, Sensorion.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Engage, Gilead, Merck, Provention, QED, Tenax.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Gilead, Medday, Oncternal, Redhill.